AnalystsMatthew AndrewsMatthew Andrews's Stock Forecasts
AnalystsMatthew Andrews
Sectors:
Industries:
Analyst Ranking
Top 43%
#2394 out of 5550 analysts
Average Return
+7.15%
Win Rate
57%4 out of 7
Risk vs Reward
Poor
Good
Matthew Andrews's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Tg Therapeutics IncTGTX | +165.81% | $10.12 | $26.90 | 2023-11-01 - 2024-11-01 | Strong Buy |
Tg Therapeutics IncTGTX | +18.75% | $12.00 | $14.25 | 2017-04-25 - 2018-04-25 | Strong Buy |
Tvardi Therapeutics IncTVRD | +10.98% | $560.88 | $622.44 | 2019-02-06 - 2020-02-06 | Strong Buy |
Tvardi Therapeutics IncTVRD | +8.68% | $771.84 | $838.80 | 2018-09-13 - 2019-09-13 | Strong Buy |
Matthew Andrews Analyst Color
Get additional color on Matthew Andrews's coverage of popular stocks
Matthew Andrews's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Tg Therapeutics IncTGTX | 2 | Strong Buy | N/A | N/A | Maintains | 3 years ago |
Tvardi Therapeutics IncTVRD | 2 | Strong Buy | $264.00 | N/A | Assumes | 8 years ago |
Allena Pharmaceuticals IncALNAQ | 2 | Strong Buy | $22.00 | N/A | Assumes | 8 years ago |
Cti Biopharma CorpCTIC | 1 | Strong Buy | $7.50 | N/A | Initiates Coverage On | 9 years ago |
Aevi Genomic Medicine IncGNMX1 | 1 | Hold | $2.50 | N/A | Downgrades | 10 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.